We are live on ! Find out more
NPF

Norris Perne & French Portfolio holdings

AUM $1.71B
1-Year Est. Return 30.87%
This Fund
S&P 500
This Quarter Est. Return
+3.62%
1 Year Est. Return
+30.87%
3 Year Est. Return
+78.29%
5 Year Est. Return
+102.93%
10 Year Est. Return
+464.45%
AUM
$508M
AUM Growth
+$27.1M
Cap. Flow
+$12M
Cap. Flow %
2.36%
Top 10 Hldgs %
27.64%
Holding
153
New
11
Increased
50
Reduced
66
Closed
5

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$6.12M
2
SBUX icon
Starbucks
SBUX
+$4.9M
3
BUD icon
AB InBev
BUD
+$3.89M
4
AMZN icon
Amazon
AMZN
+$3.51M
5
SRCL
Stericycle Inc
SRCL
+$3.26M

Top Sells

Rank Stock Value
1
SYK icon
Stryker
SYK
+$5.82M
2
MCK icon
McKesson
MCK
+$2.73M
3
ABT icon
Abbott
ABT
+$2.7M
4
VFC icon
VF Corp
VFC
+$2.29M
5
NKE icon
Nike
NKE
+$828K

Sector Composition

Rank Sector Weight
1 Financials 14.55%
2 Industrials 13.47%
3 Healthcare 13.3%
4 Consumer Discretionary 12.8%
5 Technology 11.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
26
PayPal
PYPL
$50.5B
$6.94M 1.37%
175,780
-4,190
-2% -$168K
NXPI icon
27
NXP Semiconductors
NXPI
$60.4B
$6.92M 1.36%
70,590
+9,420
+15% +$936K
LKQ icon
28
LKQ Corp
LKQ
$6.29B
$6.88M 1.35%
224,360
+790
+0.4% +$25.8K
NKE icon
29
Nike
NKE
$61.9B
$6.82M 1.34%
134,216
-16,149
-11% -$828K
CBRE icon
30
CBRE Group
CBRE
$42.9B
$6.72M 1.32%
213,525
-2,905
-1% -$84.1K
ABT icon
31
Abbott
ABT
$187B
$6.71M 1.32%
174,811
-68,141
-28% -$2.7M
SLB icon
32
SLB Ltd
SLB
$75B
$6.48M 1.28%
77,194
+658
+0.9% +$53.9K
CRL icon
33
Charles River Laboratories
CRL
$12.8B
$6.38M 1.26%
83,700
+285
+0.3% +$21.6K
COF icon
34
Capital One
COF
$134B
$6.3M 1.24%
72,217
-237
-0.3% -$19.1K
UNP icon
35
Union Pacific
UNP
$174B
$6.28M 1.24%
60,583
+640
+1% +$62.9K
SRCL
36
DELISTED
Stericycle Inc
SRCL
$6.06M 1.19%
78,655
+43,225
+122% +$3.26M
SBUX icon
37
Starbucks
SBUX
$120B
$5.88M 1.16%
105,860
+88,520
+510% +$4.9M
WFC icon
38
Wells Fargo
WFC
$264B
$5.77M 1.14%
104,769
-2,461
-2% -$124K
OMC icon
39
Omnicom Group
OMC
$23.4B
$5.48M 1.08%
64,352
+236
+0.4% +$19.8K
BALL icon
40
Ball Corp
BALL
$16.8B
$5.46M 1.08%
145,594
+75,202
+107% +$2.91M
BRK.A icon
41
Berkshire Hathaway Class A
BRK.A
$1.12T
$5.37M 1.06%
22
KNGT
42
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
$5.17M 1.02%
156,558
-320
-0.2% -$10.6K
WWAV
43
DELISTED
The WhiteWave Foods Company
WWAV
$5.17M 1.02%
92,910
-6,855
-7% -$375K
NVS icon
44
Novartis
NVS
$297B
$5.04M 0.99%
77,184
-6,939
-8% -$450K
IBM icon
45
IBM
IBM
$224B
$4.93M 0.97%
31,059
-151
-0.5% -$23K
MDLZ icon
46
Mondelez International
MDLZ
$79.9B
$4.85M 0.96%
109,455
-1,397
-1% -$60.2K
VFC icon
47
VF Corp
VFC
$5.89B
$4.67M 0.92%
92,988
-44,213
-32% -$2.29M
IJH icon
48
iShares Core S&P Mid-Cap ETF
IJH
$127B
$4.52M 0.89%
136,720
+4,855
+4% +$154K
NUVA
49
DELISTED
NuVasive, Inc.
NUVA
$4.48M 0.88%
66,560
+5,775
+10% +$372K
CSCO icon
50
Cisco
CSCO
$479B
$4.41M 0.87%
145,944
+14,594
+11% +$445K

Similar funds

Norris Perne & French's Q4 2016 Portfolio in Review

As of Q4 2016, Norris Perne & French held 153 positions worth $508M, up 5.6% from $481M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Norris Perne & French's Q4 2016 filing shows 11 new, 50 increased, 66 reduced and 5 closed positions. Its largest new stake was AB InBev: 34,743 shares worth $3.66M. The largest sale was Stryker, an estimated $5.82M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Healthcare.

  • Norris Perne & French's largest Q4 2016 buy was AB InBev: 34,743 shares worth $3.66M.
  • Norris Perne & French added most to Visa in Q4 2016, an estimated $6.12M increase.
  • Norris Perne & French's biggest Q4 2016 reduction was Stryker, cutting an estimated $5.82M.
  • Norris Perne & French fully exited McKesson in Q4 2016, selling an estimated $2.73M.
  • Norris Perne & French's ten largest holdings make up 28% of its $508M portfolio in Q4 2016.
  • Norris Perne & French opened 11 new positions and closed 5 in Q4 2016.
  • Norris Perne & French's portfolio value rose 5.6% quarter-over-quarter to $508M.

Based on Norris Perne & French's 13F filing for Q4 2016, filed 7 Feb 2017.